From The Messenger
Individual life insurance is a voluntary purchase decision and for it to remain a viable product, insureds must pay premiums commensurate with their risks. While premiums fund most of the cost of life claims, the balance comes from return on investments, so the timing of claims is very important.

Life expectancy (LE) as a summary statistic for mortality gained popularity because it is a single number that seems to capture what one needs to know about mortality. Popular in the press and with the government agencies charged with health policy decisions, LE has long been used as the measure of expected survival in structured settlements.

More recently, life expectancy has been used as a measure of expected mortality in viaticals and life settlements and as a measure of comparative mortality in the medical literature.

Read the complete article by Dr. David Wesley, MD in the most recent edition of The Messenger.

With the downturn in financial markets, and a concern that current conditions may be with us for some time, many term life insurers are revisiting their pricing and product design strategies.

Bill Winterman, Second Vice President & Pricing Leader

Read Bill's complete article from the latest edition of The Messenger